Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010539
Filing Date
2025-05-15
Accepted
2025-05-15 08:30:27
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 421991
2 ex31-1.htm EX-31.1 7617
3 ex31-2.htm EX-31.2 7582
4 ex31-3.htm EX-31.3 7579
5 ex32-1.htm EX-32.1 5738
6 form10q_001.jpg GRAPHIC 30056
  Complete submission text file 0001641172-25-010539.txt   3429139

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cocp-20250331.xsd EX-101.SCH 28121
8 XBRL CALCULATION FILE cocp-20250331_cal.xml EX-101.CAL 40377
9 XBRL DEFINITION FILE cocp-20250331_def.xml EX-101.DEF 110067
10 XBRL LABEL FILE cocp-20250331_lab.xml EX-101.LAB 292162
11 XBRL PRESENTATION FILE cocp-20250331_pre.xml EX-101.PRE 232865
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 343235
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 25948922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)